Eliglim MV2 Tablet
Eliglim MV2 Tablet
Introduction to Eliglim MV2 Tablet
Eliglim MV2 Tablet is a prescription-only medicine and is a potent triple drug combination formulated with Voglibose, Glimepiride, and Metformin hydrochloride to deliver effective control over Type II diabetes. This specialized medication is recommended for challenging cases, ensuring comprehensive management of diabetes.
Voglibose contributes by retarding the digestion and absorption of carbohydrates, Glimepiride stimulates insulin secretion, and Metformin Hydrochloride (SR) enhances insulin sensitivity. Together, they form a powerful trio targeting different aspects of glucose control, providing a multifaceted strategy against Type II diabetes.
Typically, it is taken orally, and the dosage may vary based on individual health parameters. It is often recommended to take the medication with a meal to optimize its effectiveness.
Users should be aware of potential side effects. These may include gastrointestinal discomforts such as diarrhea, abdominal pain, and nausea. Fluctuations in blood sugar levels and other reactions are possible Promptly report any adverse effects to your healthcare professional.
Individuals with specific health conditions, such as kidney or liver disorders, should exercise caution. Pregnant or breastfeeding individuals, as well as those with known allergies to any of the components, should consult their healthcare provider before starting this medication.
In the event of a missed dose, take it as soon as remembered unless it's close to the next scheduled dose. Do not double up to compensate for a missed dose.
Related Faqs
Are there any specific conditions in which Glimda-MV 2 Tablet SR should not be taken?
Patients who have a known allergy to any of the ingredients or excipients present in GlimdaMV 2 Tablet SR should refrain from using this medication It is similarly contraindicated for individuals with moderate to severe kidney disease Additionally patients with inflammatory bowel disease colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis are also advised against taking this medicine Patients who have experienced an allergic reaction to GlimdaMV 2 Tablet SR or any of its components should avoid using this medication Furthermore individuals with significant kidney impairment should not take this medicine It is also not recommended for patients with inflammatory bowel disease colonic ulcerations or underlying metabolic acidosis such as diabetic ketoacidosis Those who have a known hypersensitivity to the ingredients or excipients in GlimdaMV 2 Tablet SR should refrain from using this medication Likewise individuals with moderate to severe kidney disease and patients with inflammatory bowel disease colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis should avoid taking this medicine Patients who have a known allergy to any of the components or excipients of GlimdaMV 2 Tablet SR should refrain from using this medication Similarly individuals with moderate to severe kidney disease and patients who have inflammatory bowel disease colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis should avoid taking this medicine It is imperative that patients who have a known allergic reaction to any of the ingredients or excipients of GlimdaMV 2 Tablet SR should avoid using this medication Additionally this medicine is not recommended for patients with moderate to severe kidney disease or those with inflammatory bowel disease colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis
What are the instructions for the storage and disposal of Glimda-MV 2 Tablet SR?
To ensure the effectiveness and safety of this medication it is crucial to store it appropriately Always keep the medicine in its original packet or container making sure to tightly close it after each use Follow the storage instructions provided on the packaging or label to maintain its stability and potency Proper storage conditions can vary depending on the medication so it is important to refer to the specific guidelines outlined When it comes to disposing of any unused medication take extra care to prevent accidental consumption by pets children or other individuals Safely discard the medicine in a responsible manner as per the recommended disposal procedures By practicing proper storage and disposal methods you can play an active role in promoting medication safety for both yourself and those around you
What is Glimda-MV 2 Tablet SR?
Glimda-MV 2 Tablet SR is a combination of three medicines: Glimepiride, Metformin and Voglibose. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves the blood glucose levels in adults when taken along with proper diet and regular exercise. Glimepiride lowers the blood glucose levels by increasing the release of insulin from the pancreas. Metformin works by lowering the glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor which lowers the postprandial (after meals) glucose levels in the body. This combination is not indicated for the treatment of Type 1 DM.
Are there any specific conditions in which Eliglim MV should not be taken?
It is strongly advised to refrain from using Eliglim MV in individuals who have a documented allergy to any of the ingredients or additives present in this medication Furthermore it is not recommended to administer this medicine to patients who have moderate to severe kidney disease Additionally individuals who suffer from inflammatory bowel disease colonic ulcerations or underlying metabolic acidosis including diabetic ketoacidosis should also avoid the use of this medicine It is crucial to prioritize patient safety and wellbeing when considering the appropriate use of Eliglim MV Therefore healthcare professionals should carefully evaluate each patients medical history and conditions before prescribing this medication If the patient falls within any of the aforementioned categories alternative treatment options should be explored to ensure the best possible outcome and minimize potential risks Remember it is essential to follow the guidance and recommendations of qualified healthcare professionals when it comes to medication usage to ensure optimal results and prevent adverse reactions
What is Eliglim MV?
Eliglim MV is a medication that combines three active ingredients Glimepiride Metformin and Voglibose It is primarily prescribed for the management of type 2 diabetes mellitus DM By adhering to a proper diet and engaging in regular exercise this medication helps to improve blood glucose levels in adults Its effectiveness can be attributed to the individual actions of each component Glimepiride stimulates the release of insulin from the pancreas resulting in decreased blood glucose levels Metformin on the other hand works by reducing glucose production in the liver and enhancing the bodys sensitivity to insulin Lastly Voglibose acts as an alphaglucosidase inhibitor effectively decreasing postprandial after meals glucose levels It is important to note that this combination medication is not recommended for the treatment of Type 1 DM
What are the possible side effects of Eliglim MV?
Eliglim MV a medication commonly prescribed for managing diabetes can have a range of side effects One of the most common side effects experienced by individuals taking Eliglim MV is hypoglycemia characterized by abnormally low blood sugar levels Nausea and diarrhea are also frequently reported causing discomfort and potential disruption to daily activities Furthermore altered taste flatulence and stomach pain are commonly observed side effects which may affect an individuals overall wellbeing Headaches are another common occurrence potentially causing mild to moderate discomfort In some cases individuals may experience a skin rash as an adverse reaction to Eliglim MV Lastly respiratory tract infections have been associated with the use of this medication making individuals more susceptible to respiratory illnesses While these side effects are known to occur it is important to note that not everyone will experience them and the severity may vary from person to person As with any medication it is advisable to consult a healthcare professional for personalized guidance and to discuss any concerns or adverse reactions when taking Eliglim MV
Disclaimer : This information is not a substitute for medical advice. Consult your healthcare provider before making any changes to your treatment . Do not ignore or delay professional medical advice based on anything you have seen or read on Medwiki.
Eliglim MV2 Tablet
Prescription Required
Packaging :
strip of 10 tablets
Manufacturer :
Elion Health Care LtdMRP :
Related Posts
1:15
5 Healthier Sugar Alternatives!
1:15
Pregnancy and Diabetes: What to Eat? | Foods to Eat for Gestational Diabetes!
1:15
Panic Attacks: Symptoms, Causes, and ways to Prevent Panic Attacks!
1:15
3 Practical Tips to Improve Quality of Life for Dementia Patients!
1:15
Vidya Balan's Weight Loss: Proven Tips for Your Dream Body!
1:15
3 lifestyle changes that can help reduce the risk of Dementia!
1:15
The Impact of long term untreated Sleep Apnea on Your Health!
.svg)
